Full rings for a functionalized layer insert of an ophthalmic lens
US-9195075-B2 · Nov 24, 2015 · US
US10361405B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10361405-B2 |
| Application number | US-201514949950-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 24, 2015 |
| Priority date | Aug 21, 2014 |
| Publication date | Jul 23, 2019 |
| Grant date | Jul 23, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Designs, strategies and methods to form energization elements comprising polymer electrolytes are described. In some examples, the biocompatible energization elements may be used in a biomedical device. In some further examples, the biocompatible energization elements may be used in a contact lens.
Opening claim text (preview).
What is claimed is: 1. A biomedical device comprising: an electroactive component; a primary battery including an anode current collector, a cathode current collector, an anode, a dry polymer electrolyte comprising an ionic species, and a transition metal oxide cathode, wherein the dry polymer electrolyte is laminated to a transition metal oxide deposit and to the anode; and a first biocompatible encapsulating layer, wherein the first biocompatible encapsulating layer encapsulates at least the dry polymer electrolyte, the metal oxide deposit, and the cathode current collector. 2. The biomedical device of claim 1 , wherein the anode comprises zinc, wherein the anode and the anode current collector are a single layer, and wherein the transition metal oxide cathode comprises manganese. 3. The biomedical device of claim 2 , wherein the composition of the electrolyte comprises poly (vinylidene fluoride). 4. The biomedical device of claim 3 , wherein the composition of the electrolyte comprises zinc ion. 5. The biomedical device of claim 4 , wherein the composition of the manganese dioxide cathode comprises jet milled electrolytic manganese dioxide. 6. The biomedical device of claim 4 , wherein the composition of the manganese dioxide cathode comprises poly(vinylidine fluoride). 7. The biomedical device of claim 6 , wherein the composition of the manganese dioxide cathode comprises carbon black. 8. The biomedical device of claim 7 , wherein the zinc anode is a foil of zinc. 9. The biomedical device of claim 1 , wherein the battery comprises a seal in encapsulating films that enclose the battery portions not used for making external contacts. 10. The biomedical device of claim 1 , wherein the thickness of the battery is less than 1 mm at least along a first dimension of the extents of the battery. 11. The biomedical device of claim 1 , wherein the thickness of the battery is less than 500 microns at least along a first dimension of the extents of the battery. 12. The biomedical device of claim 1 , wherein the thickness of the battery is less than 250 microns at least along a first dimension of the extents of the battery. 13. The biomedical device of claim 12 , wherein the shape of the battery is curvilinear.
of manganese · CPC title
Producing electro-active lenses or lenses with energy receptors, e.g. batteries or antennas · CPC title
Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00) · CPC title
Electricity · mapped topic
Selection of materials as electrolytes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.